Dr. Brian Cole Awarded Inaugural Allosource Inspiration Award

AlloSource, in recognition of its work with Dr. Steven Gitelis of Midwest Orthopaedics atDr. Cole Allosource_optimized.jpg Rush, recently created the “Dr. Steven Gitelis Inspiration Award,” honoring a doctor or clinician that inspires through his or her work in treating patients with donated human allografts. The first recipient of this award is Dr. Brian Cole, also of Midwest Orthopaedics of Rush, in recognition of his work using allografts to help his patients heal from a variety of injuries.

Dr. Gitelis, one of the founding physicians of AlloSource, specializes in orthopedic oncology and understands the need for donated human tissue to heal patients. Throughout his career as an orthopedic surgeon, Dr. Gitelis has used donated human tissue in complex surgical procedures. He and his patients appreciate and revere the gift of human tissue donation.

“Dr. Gitelis is a thought leader in the area of allograft research. I am honored to receive this award and grateful to all those who have helped make this happen at my office, Gift of Hope and Allosource,” said Dr. Cole.


The award was presented at the Midwest Orthopaedics at Rush offices in Chicago by Tom Cycyota, President and CEO, AlloSource and Anne Gulota, chairperson, Gift of Hope.

Allo_ESPN_logo-banner_300x250_04-16

The Role of Hyaluronic Acid Versus Platelet-Rich Plasma in Treating Osteoarthritis

A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intraarticular Biology for the Treatment of Knee Osteoarthritis

By: Brian J. Cole, MD, MBA, Vasili Karas, MD, MS, Kristen Hussey, MS, Kyle Pilz, MMS, PA-C, and Lisa A. Fortier, DVM, PhD, DACVS Investigation performed at the Rush University Medical Center, Chicago, Illinois

Purpose: To compare the clinical and biological effects of an intra-articular injection of PRP with those of an intra-articular injection of HA in patients with mild to moderate knee OA. Interview originally published in the American Journal of Sports Medicine as a February Podcast.

bcmdThe use of plateletrich plasma (PRP) for the treatment of osteoarthritis (OA) has demonstrated mixed clinical outcomes in randomized controlled trials when compared with hyaluronic acid(HA), an accepted nonsurgical treatment for symptomatic OA. Biological analysis of PRP has demonstrated an anti-inflammatory effect on the intra-articular environment.

We found no difference between HA and PRP at any time point in the primary outcome measure: the patient-reported WOMAC pain score. Significant improvements were seen in other patient-reported outcome measures, with results favoring PRP over HA. Preceding a significant difference in subjective outcomes favoring PRP, there was a trend toward a decrease in 2 proinflammatory cytokines, which suggest that the anti-inflammatory properties of PRP may contribute to an improvement of symptoms.

Click here to read the article.

Treatment Options for Small Articular Cartilage Lesions

Jack Farr II, MD, (Indianapolis, IN) and Brian Cole, MD, MBA, (Chicago, IL) review the treatment options for small articular cartilage lesions. The available treatment options include debridement, marrow stimulation with the PowerPick™ instrument, Osteochondral Autograft Transplantation (OATS® technique) and BioCartilage® Cartilage Extracellular Matrix to augment a traditional microfracture or marrow stimulation procedure.

BCMD white arthrexweblogo2x

A Surgeon’s Intuition: Listen Before You Operate

Dr. Brian Cole, orthopaedic surgeon and Head Team Physician for the Chicago Bulls and a Co-Team physician for the Chicago White Sox, talks about how surgeons must learn to listen to their patients before proceeding with surgical treatment. Balancing test results and protocol alongside surgical intuition is key to better health outcomes for our patients. A must watch for patients, practicing and future physicians.

Created and Contributed by DocThoughtsMed.com

DocThoughts is a media platform that interviews thought leaders in medicine and produces 5-minute films. DocThoughts gives millennial learners an insider’s perspective on topics that are not traditionally covered in the didactic curriculum. We talk to experts such as deans, entrepreneurs, and physicians about their stories in a personal and informal atmosphere.

Treatment Options for Medium Articular Cartilage Lesions

Jack Farr II, MD, (Indianapolis, IN) and Brian Cole, MD, MBA, (Chicago, IL) discuss various treatment options available for medium-sized articular cartilage lesions. Depending on lesion location, patient age and comorbidities, treatment options may range between BioCartilage® Cartilage Extracellular Matrix augmented marrow stimulation, Cartiform®* Viable Osteochondral Allograft and especially in revision procedures, Fresh Osteochondral Allograft. *Cartiform is a registered trademark of Osiris Therapeutics, Inc.

arthrexweblogo2xBCMD white